Viemed Healthcare Raises 2026 Guidance After Investor Day Viemed set 2026 revenue guidance of $225–235m and adjusted EBITDA $30–35m at its Mar 22, 2026 investor day (Yahoo Finance), signaling a shift to recurring revenue.

Viemed Healthcare Raises 2026 Guidance After Investor Day: Viemed set 2026 revenue guidance of $225–235m and adjusted EBITDA $30–35m at its Mar 22, 2026 investor day (Yahoo Finance), signaling… 👈 Read full analysis #ViemedHealthcare #InvestorDay #RevenueGuidance #BusinessGrowth #HealthcareInvestment